About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 341 record(s)
Req # A-2020-09098
Copies of all records discussing the impacts of the regulatory changes to the PMPRB from August 2019 until August 2020. Copies of all correspondence from all pharmaceutical companies expressing their concerns with the changes and any responses back to these companies. Copies of all correspondence from all advocating groups expressing concerns with the changes and any responses back to these groups. Copies of all correspondence between departmental staff discussing the impacts of the regulatory changes to the PMPRB. Copies of all records discussing the impacts of the PMPRB changes on individuals living with rare diseases. Copies of all correspondence from Vertex Pharmaceuticals relating to Kalydeco, Orkambi, Symdeko, and Trikafta. Copies of all correspondence between government officials (Prime Minister, Ministers, all members of parliament, constituency staff, deputies, assistant deputies, directors, managers, supervisors, staff, and any other employee of the Government of Canada relating to the PMPRB regulatory changes. Copies of all presentations relating to the PMPRB regulatory changes.Organization: Patented Medicine Prices Review Board Canada
September 2020
Nothing to report this month
Organization: Veterans Review and Appeal Board
Req # A-2020-01436
Copies of reports, discussions, briefings, memos and decisions related to the introductory price review for erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
August 2020
Req # A-2020-04137
Copies of the PMPRB documentation related to the scientific review and pricing review of erenumab (Aimovig) from January 2018 to February 2020.Organization: Patented Medicine Prices Review Board Canada
August 2020
Nothing to report this month
Organization: Veterans Review and Appeal Board
Nothing to report this month
Organization: Veterans Review and Appeal Board
Req # A-2020-00005
Temporary Help Services (THS) Supply Arrangement (SA) and Standing Offer (SO) callups issued in the National Capital Region for the months, October 2019, November 2019, December 2019, January 2020, February 2020 & March 2020.Organization: Office of the Superintendent of Financial Institutions Canada
June 2020
Req # A-2020-00006
Task & Solutions Professional Services (TSPS) and Task Based Informatics Professional Services (TBIPS) Supply Arrangement (SA) contracts and Standing Offer (SO) callups issued in the National Capital Region for the months of October 2019, November 2019, December 2019, January 2020, February 2020 & March 2020.Organization: Office of the Superintendent of Financial Institutions Canada
June 2020
Req # A-2020-00007
ProServices contracts issued in the National Capital Region for the months, October 2019, November 2019, December 2019, January 2020, February 2020 & March 2020.Organization: Office of the Superintendent of Financial Institutions Canada
June 2020
Req # A-2020-00013
Drafts of briefing notes, memos, and slide decks, that discuss, reference, or make mention to liquidity or funding vulnerabilities within Canada's domestic systemically important banks (D-SIBS) as a result, or coinciding with, the onset of the COVID-19 pandemic and the corresponding impact on economic activity. Exclude emails. Include records received or originating from Finance Canada or Canada Mortgage and Housing Corporation. Include any records that make policy suggestions to support the stability of D-SIBS (including any recommendations related to the Insured Mortgage Purchase Program, expanding liquidity facilities for lenders through the government or central bank, or a relaxation of the Liquidity Adequacy Requirements (LAR) Guideline) between March 1 to June 11, 2020.Organization: Office of the Superintendent of Financial Institutions Canada
June 2020